US EditionDemocratizing Artificial Intelligence In Pre-Clinical Drug Discovery - Data Intelligence
3 Articles
3 Articles
Artificial intelligence-driven pharmaceutical industry: A paradigm shift in drug discovery, formulation development, manufacturing, quality control, and post-market surveillance
The advent of artificial intelligence (AI) has catalyzed a profound transformation in the pharmaceutical industry, ushering in a paradigm shift across…
Democratizing Artificial Intelligence In Pre-Clinical Drug Discovery - Data Intelligence
Most breakthrough discoveries are made based on evidence that’s already there,” Ming-Ming Zhou, PhD, asserted in his New York City office as we overlooked a cloudy Central Park. “It takes somebody to connect the dots in a different way to solve the problem.” Zhou began his faculty career in 1997 and is currently a professor in physiology and biophysics at the Icahn School of Medicine at Mount Sinai. His lab designs chemical compounds to modulate…
Democratizing Artificial Intelligence in Pre-Clinical Drug Discovery
Most breakthrough discoveries are made based on evidence that’s already there,” Ming-Ming Zhou, PhD, asserted in his New York City office as we overlooked a cloudy Central Park. “It takes somebody to connect the dots in a different way to solve the problem.” Zhou began his faculty career in 1997 and is currently a professor in physiology and biophysics at the Icahn School of Medicine at Mount Sinai. His lab designs chemical compounds to modulate…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
